Publications

Detailed Information

The Autophagic Adaptor p62 Binds to Destabilizing N-terminal Residues of the N-end Rule Pathway.

DC Field Value Language
dc.contributor.advisor윤홍덕-
dc.contributor.author장준민-
dc.date.accessioned2017-07-19T11:05:06Z-
dc.date.available2017-07-19T11:05:06Z-
dc.date.issued2014-02-
dc.identifier.other000000017159-
dc.identifier.urihttps://hdl.handle.net/10371/133338-
dc.description학위논문 (석사)-- 서울대학교 융합과학기술대학원 : 분자의학 및 바이오제약학과, 2014. 2. 윤홍덕.-
dc.description.abstractThe N-end rule pathway is a proteolytic system in which a destabilizing N-terminal residue {type 1 (Arg, Lys, His) and type 2 (Phe, Trp, Tyr, Lue, Ile) in mammals} acts as a degradation signal (N-degron). Known functions of the pathway include the regulated proteolysis of short-lived proteins through the ubiquitin-proteasome system. So far, known N-recognins include UBR1, UBR2, UBR4 and UBR5, which possess an evolutionally conserved 72-residue UBR box that is required for recognizing N-degrons. We used synthetic peptides carrying N-terminal destabilizing residues to purify recognition components (N-recognins) of the pathway. Our proteomic screen for N-degron binding proteins identified p62/SQSTM1 known to mediate autophagic degradation of aberrant proteins as a new recognition component of the N-end rule pathway. In this study, we characterized the binding specificity and other biochemical properties of p62 as a potential N-recognin of the N-end rule pathway. Pull-down assays with synthetic N-end rule peptides show that its ZZ domain whose function had remained unclear is responsible for the binding to N-end rule N-termini. p62 binds N-terminal Arg and other type-1 peptides (Lys and His) as well as a subset of type-2 peptides (Phe, Trp and Tyr) but not Leu and Ile. Site-directed mutagenesis revealed specific residues critical for the interaction with N-end rule peptides and conserved in p62 and known N-recognins. And the surface plasmon resonance biacore assay again demonstrated that the interaction between p62 and destabilizing N-end rule N-termini. Our results suggest that p62 may be a new recognition component of the N-end rule pathway and hints that to be an effective autophagy inducer, a ligand should have high affinity to the ZZ domain.-
dc.description.tableofcontentsAbstract(i)
Table of contents(iii)
List of figure(v)
1. Introduction(1)
2. Materials and Methods(7)
2.1 Plasmid and antibodies(7)
2.2 Cell culture and immunoblotting(8)
2.3 Overexpression of p62 protein in HEK293 and pull down preaparation(8)
2.4 X-peptide pull down assay(9)
2.5 Surface Plasmon Resonance (Biacore) assay(11)
3. Results(12)
3.1 p62 is a selective autophagy substrate with high affinity for N-terminal Arg and may be a new component of the N-end rule pathway(12)
3.2 p62 can bind a broad range of type-1 and type-2 N-end rule N-termini(15)
3.3 The ZZ type zinc finger domain is responsible for the binding to N-end rule N-termini(18)
3.4 The amino acids components of the C2H2 Zinc finger structure are important for binding of Type-1 and Type-2 N-end rule substrates(22)
3.5 The Zinc finger domain of p62 is important of binding to Type-1 and Type-2 N end rule N-termini26)
3.6 Surface Plasmon resonance (Biacore) analysis of the interaction between p62-D3-GST (E.coli expressed) and X-peptide (X=Arg, Phe or Val)(29)
3.7 GRP78 ER chaperone protein is a new N-end rule substrate(31)
4. Discussion (33)
5. Reference(36)
6. Abstract in Korean(41)
-
dc.formatapplication/pdf-
dc.format.extent2009799 bytes-
dc.format.mediumapplication/pdf-
dc.language.isoen-
dc.publisher서울대학교 대학원-
dc.subjectN-end rule pathway-
dc.subjectp62-
dc.subject.ddc610-
dc.titleThe Autophagic Adaptor p62 Binds to Destabilizing N-terminal Residues of the N-end Rule Pathway.-
dc.typeThesis-
dc.contributor.AlternativeAuthorJun Min Jang-
dc.description.degreeMaster-
dc.citation.pages42-
dc.contributor.affiliation융합과학기술대학원 분자의학 및 바이오제약학과-
dc.date.awarded2014-02-
Appears in Collections:
Files in This Item:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share